South Korea
· Delayed Price · Currency is KRW HansBiomed Company Description
HansBiomed Corporation, together with its subsidiaries, engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies.
The company provides ExFuse, a demineralized bone matrix with cancellous bone gel/putty; BellaFuse, a demineralized bone matrix; Genesis, a cancellous sponge block/filler; Pedi-Stick, a demineralized cortical bone stick; SureChip, a cancellous bone chip; OsteoGrow, a demineralized bone matrix inserter; BellaCell HD, an allograft dermal product that transplanted in a patient whose skin has been lost due to breast cancer; and SureDerm, an acellular dermal matrix.
It also offers BELLAGEL, a breast prosthesis, internal, and gel-filled solution; MINT Lift, a PDO thread; EZ-Tcon solution; Lion HT/HN, a hair transplanter body/needle; and Scar Clinic, a scar management solution.
The company was formerly known as Hans Medical Corp. and changed its name to HansBiomed Corporation in June 2000.
The company was founded in 1990 and is headquartered in Seoul, South Korea.
| Country | South Korea |
| Founded | 1990 |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 127 |
| CEO | Guen Young Kim |
Contact Details
Address: 7, Jeongui-ro 8-gil Seoul, 05836 South Korea | |
| Phone | 82 2 466 2266 |
| Website | hansbiomed.com |
Stock Details
| Ticker Symbol | 042520 |
| Exchange | KOSDAQ |
| Fiscal Year | October - September |
| Reporting Currency | KRW |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Guen Young Kim | Chief Executive Officer |
| Seok-Bae Oh | Chief Financial Officer |